Literature DB >> 2393714

Clinical spectrum and diagnosis of cobalamin deficiency.

S P Stabler1, R H Allen, D G Savage, J Lindenbaum.   

Abstract

To better estimate how frequently patients with low serum cobalamin (Cbl) levels in current clinical practice are truly deficient in Cbl and to determine the incidence of atypical or nonclassic presentations of Cbl deficiency, we prospectively studied 300 unselected consecutive patients with serum Cbl concentrations less than 200 pg/mL seen at two medical centers over a 2-year period. Baseline hematologic, neuropsychiatric, and biochemical measurements were obtained, followed by a course of parenteral Cbl therapy and reassessment. A response to Cbl therapy was defined as one or more of the following: (1) an increase in hematocrit of 0.05 or more; (2) a decrease in mean cell volume of 5 fL or more; (3) a clearing of hypersegmented neutrophilis and macroovalocytes from the peripheral blood smear; and (4) an unequivocal and prompt improvement of neuropsychiatric abnormalities. Of the 300 patients with serum Cbl levels less than 200 pg/mL, 86 had one or more responses to Cbl therapy and 59 had no response. In 155, insufficient data was available. In the Cbl-responsive patients, normal values were found for the following tests: hematocrit, 44%; mean cell volume less than or equal to 100 fL, 36%; white blood cell count, 84%; platelet count, 79%; serum lactic dehydrogenase, 43%; and serum bilirubin, 83%. Peripheral blood smears were nondiagnostic in 6% when reviewed by the investigators, but 33% as reported by routine laboratories. Serum Cbl levels in the 100 to 199 pg/mL range were present in 38%. Neuropsychiatric abnormalities were noted in 28%, often in the absence of anemia, macrocytosis, or both. Serum levels of methylmalonic acid and/or total homocysteine were elevated greater than 3 SDs above the mean for normal subjects in 94% of the Cbl-responsive patients. We conclude that Cbl deficiency should be considered and investigated in patients with unexplained hematologic or neuropsychiatric abnormalities of the kind seen in Cbl deficiency, even if anemia, an elevated mean cell volume, a marked depression of the serum Cbl, or other classic hematologic or biochemical abnormalities are lacking. Levels of serum methylmalonic acid and total homocysteine are useful as ancillary diagnostic tests in the diagnostis of Cbl deficiency.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393714

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  56 in total

1.  Formate can differentiate between hyperhomocysteinemia due to impaired remethylation and impaired transsulfuration.

Authors:  Simon G Lamarre; Anne M Molloy; Stacey N Reinke; Brian D Sykes; Margaret E Brosnan; John T Brosnan
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-09-20       Impact factor: 4.310

2.  Positive newborn screen for methylmalonic aciduria identifies the first mutation in TCblR/CD320, the gene for cellular uptake of transcobalamin-bound vitamin B(12).

Authors:  Edward V Quadros; Shao-Chiang Lai; Yasumi Nakayama; Jeffrey M Sequeira; Luciana Hannibal; Sihe Wang; Donald W Jacobsen; Sergey Fedosov; Erica Wright; Renata C Gallagher; Natascia Anastasio; David Watkins; David S Rosenblatt
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

Review 3.  [Folic acid and vitamin B12 determination in the assessment of cognitive disorders : Overview and data analysis from a university outpatient memory clinic].

Authors:  Robert Haußmann; Cathrin Sauer; Stefanie Neumann; Anne Zweiniger; Jan Lange; Markus Donix
Journal:  Nervenarzt       Date:  2019-11       Impact factor: 1.214

Review 4.  Biomarkers of Nutrition for Development (BOND): Vitamin B-12 Review.

Authors:  Lindsay H Allen; Joshua W Miller; Lisette de Groot; Irwin H Rosenberg; A David Smith; Helga Refsum; Daniel J Raiten
Journal:  J Nutr       Date:  2018-12-01       Impact factor: 4.798

Review 5.  Potential outcome factors in subacute combined degeneration: review of observational studies.

Authors:  Olavo M Vasconcelos; Erika H Poehm; Robert J McCarter; William W Campbell; Zenaide M N Quezado
Journal:  J Gen Intern Med       Date:  2006-10       Impact factor: 5.128

Review 6.  Cobalamin and folate: recent developments.

Authors:  I Chanarin; R Deacon; M Lumb; J Perry
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

Review 7.  Best practice in primary care pathology: review 1.

Authors:  W S A Smellie; D Wilson; C A M McNulty; M J Galloway; G A Spickett; D I Finnigan; D A Bareford; M A Greig; J Richards
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

8.  Biermer's anemia: a new cause of cholestasis and hepatic steatosis?

Authors:  Xavier Roblin; Maud Genevois; V Ducros; Jean-Pierre Zarski; Vincent Leroy
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

Review 9.  Macrocytosis: pitfalls in testing and summary of guidance.

Authors:  Michael Galloway; Malcolm Hamilton
Journal:  BMJ       Date:  2007-10-27

10.  Vitamin B12 deficiency presenting as acute ataxia.

Authors:  John Ross Crawford; Daphne Say
Journal:  BMJ Case Rep       Date:  2013-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.